Jacob E. Berchuck, MD, discusses how a new epigenomic platform may influence the accessibility of PSMA-based therapies, especially for patients who may not have easy access to PSMA PET scans.

The robot-assisted approach to radical prostatectomy has enabled same-day discharge. A substantial concern associated with this practice could be haemorrhage, but sound and thorough robot-assisted ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Thousands of men will be able to have a "gold standard" diagnostic imaging scan for prostate cancer in East Yorkshire from ...

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...

Chunhui Han, PhD, discusses the use of of Gallium 68 PSMA-11 in biology-guided radiotherapy and whether or not the ...

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...

The shift towards PSMA PET scans for prostate cancer diagnosis aligns well with Lantheus' product offerings, particularly Pylarify. However, the industry is also seeing intensifying competition, which ...

"Combining PSMA PET technology with simultaneous MRI by fusing the images significantly enhances the diagnostic accuracy for prostate cancer when compared to using individual mpMRI or PSMA PET scans.

A PET scan is often used to help determine a cancer diagnosis. A positron emission tomography (PET) scan uses a tracer with low levels of radiation to find places in your body where cells are ...